Management of Diabetes Mellitus Patients With Retinopathy
NCT ID: NCT00828425
Last Updated: 2010-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2500 participants
OBSERVATIONAL
2008-12-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* which medication are used to keep blood pressure under control?
* which medication are used for metabolic control?
* the average control level of metabolism and blood pressure is compliant with the international guidelines?
* laser photocoagulation plays a role in the control of metabolism and blood pressure?
* there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?
* there is an influence of renal failure on the choose of medication?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
NCT00130845
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
NCT00170742
Diabetic Retinopathy and Visual Function Study
NCT00001346
Phenotyping Diabetic Retinopathy
NCT00840541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Diabetic patients with retinopathy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetic retinopathy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Diegten, Basel-Landschaft, Switzerland
Research Site
Laufen, Basel-Landschaft, Switzerland
Research Site
Dättwil, Canton of Aargau, Switzerland
Research Site
Hausen B. Brugg, Canton of Aargau, Switzerland
Research Site
Lenzburg, Canton of Aargau, Switzerland
Research Site
Lupfig, Canton of Aargau, Switzerland
Research Site
Muri, Canton of Aargau, Switzerland
Research Site
Rheinfelden, Canton of Aargau, Switzerland
Research Site
Schinznach Dorf, Canton of Aargau, Switzerland
Research Site
Spreitenbach, Canton of Aargau, Switzerland
Research Site
Basel, Canton of Basel-City, Switzerland
Research Site
Bern, Canton of Bern, Switzerland
Research Site
Moutier, Canton of Bern, Switzerland
Research Site
Unterseen, Canton of Bern, Switzerland
Research Site
Estavayer-le-Lac, Canton of Fribourg, Switzerland
Research Site
Fribourg, Canton of Fribourg, Switzerland
Research Site
Collonge-Bellerive, Canton of Geneva, Switzerland
Research Site
Geneva, Canton of Geneva, Switzerland
Research Site
Le Grand-Saconnex, Canton of Geneva, Switzerland
Research Site
Les Acacias, Canton of Geneva, Switzerland
Research Site
Versoix, Canton of Geneva, Switzerland
Research Site
Alle, Canton of Jura, Switzerland
Research Site
Lucerne, Canton of Lucerne, Switzerland
Research Site
Rothenburg, Canton of Lucerne, Switzerland
Research Site
Le Locle, Canton of Neuchâtel, Switzerland
Research Site
Kerns, Canton of Obwalden, Switzerland
Research Site
Schaffhausen, Canton of Schaffhausen, Switzerland
Research Site
Küssnacht, Canton of Schwyz, Switzerland
Research Site
Tuggen, Canton of Schwyz, Switzerland
Research Site
Oberuzwil, Canton of St. Gallen, Switzerland
Research Site
Rorschach, Canton of St. Gallen, Switzerland
Research Site
Sankt Gallen, Canton of St. Gallen, Switzerland
Research Site
Wangs, Canton of St. Gallen, Switzerland
Research Site
Aigle, Canton of Vaud, Switzerland
Research Site
Bassins, Canton of Vaud, Switzerland
Research Site
Bex, Canton of Vaud, Switzerland
Research Site
Chateau-d'Oex, Canton of Vaud, Switzerland
Research Site
Clarens, Canton of Vaud, Switzerland
Research Site
Eysins, Canton of Vaud, Switzerland
Research Site
Lausanne, Canton of Vaud, Switzerland
Research Site
Nyon, Canton of Vaud, Switzerland
Research Site
Prilly, Canton of Vaud, Switzerland
Research Site
Renens VD, Canton of Vaud, Switzerland
Research Site
Salavaux, Canton of Vaud, Switzerland
Research Site
St-Legier, Canton of Vaud, Switzerland
Research Site
Vevey, Canton of Vaud, Switzerland
Research Site
Bassersdorf, Canton of Zurich, Switzerland
Research Site
Egg, Canton of Zurich, Switzerland
Research Site
Winterthur, Canton of Zurich, Switzerland
Research Site
Ascona, Canton Ticino, Switzerland
Research Site
Locarno, Canton Ticino, Switzerland
Research Site
Lugano, Canton Ticino, Switzerland
Research Site
Viganello, Canton Ticino, Switzerland
Research Site
Chur, Kanton Graubünden, Switzerland
Research Site
Ilanz, Kanton Graubünden, Switzerland
Research Site
Samedan, Kanton Graubünden, Switzerland
Research Site
Kreuzlingen, Thurgau, Switzerland
Research Site
Ardon, Valais, Switzerland
Research Site
Evionnaz, Valais, Switzerland
Research Site
Savièse, Valais, Switzerland
Research Site
Sierre, Valais, Switzerland
Research Site
Sion, Valais, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CCH-DUM-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.